 |
| MJNA Roars Back on News, AMSA Interview, PT Positive Results |
|
 Yesterday's Top Performer |
Company: Mantra Venture Group, Ltd. (OTCBB: MVTG)
|
End of Day:
Price: 0.22
Change (%): + 0.02 (10.00)
Volume: 28,700 |
 |
Mantra Venture Group Ltd.'s primary operating business is Mantra Energy Alternatives Ltd, a wholly owned subsidiary. Mantra's mission is to become the world leader in the production of high value, carbon negative chemicals and fuels. Its ERC system will reduce the problem greenhouse gas carbon dioxide (CO2) and convert it into a series of valuable chemicals, a form of carbon capture and recycling (CCR). There are currently 27 billion metric tons of CO2 emitted annually from fossil fuel combustion, providing an inexhaustible supply of feedstock. Mantra's first product is formic acid (HCOOH)
Company Information Sheet
|
 Hot Stock to Watch
|
Company: American Seniors Association (Pink Sheets: AMSA)
|
End of Day:
Price: 0.05
Change (%): + 0 (0.00)
Volume: 0 |
 |
A New Audio Interview With Phil Kent, of CEO American Seniors Association, is Now at SmallCapVoice.com
AUSTIN, Texas, Nov. 14, 2012 (GLOBE NEWSWIRE) - SmallCapVoice.com, Inc. announced today that a new audio interview American Seniors Association Holding Group, Inc. (OTCBB:AMSA), is now available. The interview can be heard at http://smallcapvoice.com/blog/11-13-12-smallcapvoice-interview-with-american-seniors-association-holding-group
Continue Reading
|
Company: Medical Marijuana Inc. (Pink Sheets: MJNA)
|
Last:
Price: 0.106
Change (%): + 0.016 (17.78)
Volume: 2,421,827 |
 |
Medical Marijuana, Inc. Sees Vertical and Horizontal Growth with PhytoSPHERE Subsidiary
The integration and expansion of PhytoSPHERE's state-of-the-art growing and extraction technologies give Medical Marijuana, Inc. (MJNA) the edge in production of today's and tomorrow's premium hemp oil-based products.
SAN DIEGO, Nov. 13, 2012 /PRNewswire/ - Medical Marijuana, Inc. (OTC: MJNA) has announced the integration and expansion of its PhytoSPHERE subsidiary. This move gives the nation's premier hemp nutraceutical firm full management oversight of its manufacturing and quality assurance processes for all of its existing and emerging products.
Continue Reading |
SmallCapVoice Clients' News
|
Company: Pacific Therapeutics Ltd. (CNSX: PT)
|
Pacific Therapeutics Announces Positive Results from Recent Clinical Trial of Lead Product PTL-202
VANCOUVER, BRITISH COLUMBIA- (November 13, 2012) - Pacific Therapeutics Ltd. (the "Issuer") is a development stage specialty pharmaceutical company focused on the identification and development of drug candidates to treat diseases of excessive scarring (fibrosis).
The Issuer is pleased to provide the results of the phase 1 trial of PTL-202 and an update on the development of PL-202 including future plans.
The Issuer initiated its first clinical trial of PTL-202 in August of this year. PTL-202 is a fixed dose combination of Pentoxifylline and NAC (the "Active Ingredients"). The development of PTL-202 is targeted at fibrosis including Idiopathic Pulmonary Fibrosis ("IPF") and Bronchiolitis Obliterans (excessive scarring) associated with lung transplant and Liver Cirrhosis. IPF is responsible for more deaths annually than either prostate or breast cancer.
Continue Reading |
Other Small Cap News
|
Company: Tootie Pie Company, Inc. (OTCQB: TOOT)
|
Tootie Pie in Southern Living
SAN ANTONIO, Nov. 14, 2012 /PRNewswire/ -- Tootie Pie Company, Inc. (OTCQB: TOOT) announced that its Award Winning Pies will once again be featured in the December issue of Southern Living Magazine, which hits newsstands by November 16, 2012.
"We are thrilled that the editors of Southern Living Magazine have once again chosen to feature Tootie Pies in their upcoming holiday issue," said Don Merrill, President & CEO. "Southern Living is one of America's finest sources for quality stories and holiday ideas. This is tremendous exposure for Tootie Pie and we are honored to be chosen."
Continue Reading
|
Company: NaturalNano, Inc. (OTCBB: NNAN)
|
Nanobiotechnology Report Being Presented for the Capture and Manipulation of Circulating Tumor Cells Using Halloysite Nanotubes as a Novel Biomaterial Surface at the World CTC Summit in Boston
This Nanobiotechnology presentation will demonstrate that the capture of circulating tumor cells (CTCs) in blood can be targeted more effectively by the incorporation of NaturalNano's Halloysite Natural Tubes (HNT) onto the surface of devices. These devices are used to capture circulating tumor cells (CTCs) in blood. King's Lab has been developing new methods for the isolation of intact, viable cancer cells from patient blood, based on the physiological adhesion of selectin proteins in micro-scale flow devices.
Continue Reading |
Market News
|
By Jeff Macke: Breakout
|
Housing Is the Election's Big Winner: Mills
You can barely see the move, but housing data has picked up over the last few months. Home construction is at four-year highs, according to the Commerce Department. What's more, construction permits were up 12% from August to September, a more than 90% increase over last year. The year-over-year increase was the greatest in two decades.
Ed Mills of FBR says housing was the big winner of the election, largely due to many of the plans put in place over the last four years. Because of this continuity, the Home Affordable Refinance Program (HARP) will stay in place as is, and Federal Reserve Chairman Ben Bernanke will remain for the balance of his term, which ends at the beginning of 2014 and possibly beyond.
Continue Reading
|
By Matt Nesto: Breakout
|
Dow May Shed Another 500 Points, But Bet on a Bounceback
It's arguably one of the best-known folk-rock ballads of all time, instantly recognizable from its opening line, "A long, long time ago."
Of course, I'm referring to Don McLean's American Pie, but not without reason. Maybe it's just me, but so much has happened in the markets and the world lately that even trying to recall the QE3 rally of mid-September seems like it happened such a long, long time ago. The reality is that stocks now have dug themselves into an increasingly ugly situation. In fact, this rolling recovery is quietly approaching a 7% dive, with half of that decline coming in the past week's post-election drama alone.
In some ways, it seems as if the "reasons-to-sell" list has gotten so bad I'm starting to feel that an outright correction (of 10% or more) is almost inevitable at this point. But even if I'm right and we shave another 50 points off the S&P 500, or 500 points off the Dow, would it really even be that bad? Or would it simply be setting us up to come back from Thanksgiving with a vengeance and see a powerful finish to 2012?
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the "unsubscribe" link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
